ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
ELITE PHARMACEUTICALS INC /NV/
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026
- Market cap
- $283.02M
- P/E (TTM)
- 5.0
- Dividend yield
- –
SEC filings
40 of Elite Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 29, 2026 | Jun 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Mar 31, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 1, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2026 | Apr 2, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Annual report | 10-K | Mar 31, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2025 | Jun 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2025 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 26, 2024 | Dec 26, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 2, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2024 | Nov 18, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2024 | Oct 10, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2024 | Oct 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 27, 2024 | Aug 27, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2024 | Jul 1, 2024 | SEC EDGAR |
| Annual report | 10-K | Mar 31, 2024 | Jul 1, 2024 | SEC EDGAR |